https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/accounts-payable https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/accounts-receivable https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/amortization https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/assets-noncurrent https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/basic-shares https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/capital-expenditures https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/cash-and-equivalents https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/cash-flow-breakdown https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/common-stock-value https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/cost-of-revenue https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/current-assets https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/current-liabilities https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/depreciation https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/diluted-shares https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/eps https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/eps-basic https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/financing-cash-flow https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/general-and-administrative-expense https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/gross-profit https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/income-tax https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/income-taxes-paid https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-accounts-and-notes-receivable https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/increase-decrease-in-prepaid-taxes https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/interest-expense https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/interest-paid https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/inventory https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/inventory-write-down https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/investing-cash-flow https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/investment-income-interest https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/liabilities-noncurrent https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/long-term-debt https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/minority-interest https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/minority-interest-change https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/net-change-in-cash https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/net-income https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/operating-cash-flow https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/operating-expenses https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/operating-income https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/other-long-term-investments https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/other-receivables-net-current https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/paid-in-capital-other https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/preferred-shares-facts https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/prepaid-expense-current https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/prepaid-taxes https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/proceeds-from-collection-of-longterm-loans-to-related-parties https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/profit-loss https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/property-plant-equipment https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/research-and-development https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/retained-earnings https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/revenue https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/shareholders-equity https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/shares-authorized https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/shares-issued https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/short-term-borrowings https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/short-term-investments https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/stock-based-compensation https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/total-assets https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/total-liabilities https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/china-nuokang-bio-pharmaceutical-inc/unrecognized-tax-benefits